These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Treatment
168 results:

  • 1. Anastomotic leakage following rectal cancer laparoscopic surgery: can a transanal drainage tube be an alternative to diverting stoma?
    Ho HA; Trieu TD; Nguyen MD
    Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3642-3649. PubMed ID: 38856140
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer treatments.
    Mitchell AP; Kinlaw AC; Peacock-Hinton S; Dusetzina SB; Winn AN; Sanoff HK; Lund JL
    Oncologist; 2024 Jun; 29(6):527-533. PubMed ID: 38484395
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of total neoadjuvant therapy in locally advanced rectal cancer: a survey of specialists attending the All-Ireland colorectal cancer Conference 2022 including lead investigators of OPRA, PRODIGE-23 and RAPIDO.
    O'Brien T; Hospers G; Conroy T; Lenz HJ; Smith JJ; Andrews E; O'Neill B; Leonard G
    Ir J Med Sci; 2024 Jun; 193(3):1183-1190. PubMed ID: 38141097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery.
    Procházka V; Lacina L; Smetana K; Svoboda M; Skřivanová K; Beňovská M; Jarkovský J; Křen L; Kala Z
    World J Surg Oncol; 2023 Dec; 21(1):384. PubMed ID: 38098074
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk factors for reoperation within 30 days in laparoscopic colorectal cancer surgery: A Japanese multicenter study.
    Oishi K; Tominaga T; Ono R; Noda K; Hashimoto S; Shiraishi T; Takamura Y; Nonaka T; Ishii M; Fukuoka H; Hisanaga M; Takeshita H; To K; Tanaka K; Sawai T; Nagayasu T
    Asian J Endosc Surg; 2024 Jan; 17(1):e13257. PubMed ID: 37944946
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Survival Outcome in Early-Onset Metastatic colorectal cancer: A Multicenter-Matched Pair Analysis.
    Doleschal B; Niedersüß-Beke D; Kirchweger P; Petzer A; Thaler J; Rumpold H
    Oncology; 2024; 102(2):107-113. PubMed ID: 37699362
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment and Survival Among Patients With colorectal cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study.
    Hämmerl L; Mezger NCS; Seraphin TP; Joko-Fru WY; Griesel M; Feuchtner J; Gnahatin F; Gnangnon FHR; Okerosi N; Amulen PM; Hansen R; Borok MZ; Carrilho C; Mallé B; Ahoui Apendi C; Buziba NG; Seife E; Liu B; Mikolajczyk R; Parkin DM; Kantelhardt EJ; Jemal A
    J Natl Compr Canc Netw; 2023 Sep; 21(9):924-933.e7. PubMed ID: 37673109
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Acceptability of a shared cancer follow-up model of care between general practitioners and radiation oncologists: A qualitative evaluation.
    Sandell T; Schütze H; Miller A
    Health Expect; 2023 Dec; 26(6):2441-2452. PubMed ID: 37583292
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Risk factors analysis and prediction model construction of submucosal deep infiltration of early colorectal tumor].
    Chen ZH; Dou LZ; Zhang YM; Liu Y; He S; Ke Y; Liu XD; Liu YM; Wu HR; Zou SM; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):613-620. PubMed ID: 37462018
    [No Abstract]    [Full Text] [Related]  

  • 10. Rates and Patterns of Recurrence After Microwave Ablation of colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
    Karagkounis G; McIntyre SM; Wang T; Chou JF; Nasar N; Gonen M; Balachandran VP; Wei AC; Soares KC; Drebin JA; D'Angelica MI; Jarnagin WR; Kingham TP
    Ann Surg Oncol; 2023 Oct; 30(11):6571-6578. PubMed ID: 37365414
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa.
    Mduma E; Dharsee N; Samwel K; Mwita CJ; Lidenge SJ
    JCO Glob Oncol; 2023 May; 9():e2200394. PubMed ID: 37216622
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The impact of time to surgery on oncological outcomes in stage I-III dMMR colon cancer - A nationwide cohort study.
    Justesen TF; Gögenur M; Clausen JSR; Mashkoor M; Rosen AW; Gögenur I
    Eur J Surg Oncol; 2023 Sep; 49(9):106887. PubMed ID: 37002178
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Correlation between pelvic relapses of rectal cancer after radical and R0 resection: A regression model-based analysis].
    Guo P; Tao L; Wang C; Lyu HR; Yang Y; Hu H; Li GX; Liu F; Li YX; Ye YJ; Wang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):277-282. PubMed ID: 36925128
    [No Abstract]    [Full Text] [Related]  

  • 14. The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer.
    Su YT; Chen JW; Chang SC; Jiang JK; Huang SC
    Sci Rep; 2022 Nov; 12(1):20075. PubMed ID: 36418865
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Current Practice Patterns in Locally Advanced Rectal cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and colorectal Surgeons.
    Wu TC; Sanford NN; Anand S; Chu FI; Wo JY; Raldow AC
    Clin Colorectal Cancer; 2022 Dec; 21(4):309-314. PubMed ID: 36216758
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Access to and Affordability of World Health Organization Essential Medicines for cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.
    Kizub DA; Naik S; Abogan AA; Pain D; Sammut S; Shulman LN; Martei YM
    Oncologist; 2022 Nov; 27(11):958-970. PubMed ID: 36094141
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Liu T; Jiang S; Teng X; Zhong L; Liu M; Jin Y; Dong M
    Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):1-9. PubMed ID: 35950851
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
    Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
    Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer.
    Derksen JWG; Smit KC; May AM; Punt CJA
    Eur J Cancer; 2022 May; 166():73-86. PubMed ID: 35279472
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic colorectal cancer.
    Redman JM; Tsai YT; Weinberg BA; Donahue RN; Gandhy S; Gatti-Mays ME; Abdul Sater H; Bilusic M; Cordes LM; Steinberg SM; Marte JL; Jochems C; Kim SS; Marshall JL; McMahon S; Redmond E; Schlom J; Gulley JL; Strauss J
    Oncologist; 2022 Mar; 27(3):198-209. PubMed ID: 35274710
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.